On Nov 4, 2021 XOMA closed a Post-IPO Equity round and raised $35,000,000 from Novartis, featuring lead investors Novartis. About the company: XOMA is located […]
Series A – Primmune Therapeutics
On Nov 4, 2021 Primmune Therapeutics closed a Series A round and raised $8,400,000 from investors, featuring lead investors . About the company: Primmune Therapeutics […]
Series A – Clade Therapeutics
On Nov 3, 2021 Clade Therapeutics closed a Series A round and raised $87,000,000 from Bristol Myers Squibb, Emerson Collective, LifeSci Venture Partners, Syncona Partners […]
Post-IPO Equity – ANI Pharmaceuticals
On Nov 3, 2021 ANI Pharmaceuticals closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: ANI Pharmaceuticals […]
Series A – Parthenon Therapeutics
On Nov 3, 2021 Parthenon Therapeutics closed a Series A round and raised $65,000,000 from Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Northpond […]
Series A – Sanity Group
On Nov 3, 2021 Sanity Group closed a Series A round and raised $3,500,000 from Casa Verde Capital, featuring lead investors Casa Verde Capital. About […]
Grant – Reithera Srl
On Nov 3, 2021 Reithera Srl closed a Grant round and raised $1,400,000 from Bill & Melinda Gates Foundation, featuring lead investors Bill & Melinda […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series B – Antios Therapeutics
On Nov 3, 2021 Antios Therapeutics closed a Series B round and raised $75,000,000 from Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health Investors, […]
Series B – Prilenia
On Nov 3, 2021 Prilenia closed a Series B round and raised $43,000,000 from ALS Investment Fund, Amplitude Venture Capital, Forbion Capital Partners, Morningside Venture […]
